| Liu, Ping |
NCT05064748: Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults |
|
|
| Recruiting | 4 | 2000 | RoW | Benvitimod | Peking University People's Hospital, Zhonghao Pharmaceutical | Psoriasis | 03/24 | 09/24 | | |
COPEC, NCT04922853: Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer |
|
|
| Recruiting | 3 | 554 | RoW | Capox chemotherapy | West China Hospital, The Third People's Hospital of Chengdu, Chengdu Fifth People's Hospital, Peking Union Medical College, Beijing Cancer Hospital, Sun Yat-sen University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Yunnan Cancer Hospital, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital Of Guizhou Medical University, Sichuan Provincial People's Hospital, Nanchong Central Hospital, Dazhou Central Hospital, Leshan People's Hospital, GeneCast Biotechnology Co., Ltd. | Rectal Cancer, Neoadjuvant Chemotherapy | 12/24 | 12/26 | | |
NCT06010693: A Study of Daridorexant in Chinese Patients With Insomnia Disorder |
|
|
| Recruiting | 3 | 200 | RoW | Daridorexant, Placebo | Jiangsu Simcere Pharmaceutical Co., Ltd. | Insomnia Disorder | 12/25 | 12/25 | | |
NCT06347653: Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL) |
|
|
| Recruiting | 2 | 54 | RoW | linperlisib combined with CHOP regimen | Peking University | Nodal T-follicular Helper Cell Lymphoma | 01/27 | 01/30 | | |
NCT06378177: A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC) |
|
|
| Recruiting | 2 | 64 | RoW | LVGN6051 Monoclonal Antibody Injection, LVGN6051, toripalimab Injection, Paclitaxel injection | Lyvgen Biopharma Holdings Limited | Head and Neck Squamous Cell Carcinoma | 10/27 | 10/27 | | |
NCT04509466: Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL |
|
|
| Terminated | 1/2 | 41 | RoW | Part 1: Liposomal mitoxantrone hydrochloride and Pegaspargase, Part 1, Part 2 (treatment-naïve patients): Liposomal mitoxantrone hydrochloride and Pegaspargase, Part 2 (treatment-naïve patients), Part 2 (relapsed or refractory patients): Liposomal mitoxantrone hydrochloride and Pegaspargase, Part 2 (relapsed or refractory patients) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Extranodal NK/T-cell Lymphoma, Nasal Type | 01/22 | 01/22 | | |
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies |
|
|
| Recruiting | 1/2 | 1300 | Canada, US, RoW | SKB264 | Klus Pharma Inc. | Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer | 08/25 | 07/26 | | |
NCT04711980: Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy |
|
|
| Not yet recruiting | 1 | 402 | RoW | Mudan granule, Mudan particle, Placebo, Placebos | Fengmei Lian, Peking Union Medical College Hospital, Beijing Hospital, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Affiliated Hospital of Qingdao University, Chengdu University of Traditional Chinese Medicine, The Fourth People's Hospital of Chongqing, Zhengzhou Yihe Hospital Affiliated to Henan University, Zhu Xianyi Memorial Hospital of Tianjin Medical University, The Third Hospital of Xi'an, Huashan Hospital, Gansu Provincial People's Hospital, Shenzhen Hospital of Guangzhou University of Traditional Chinese Medicine, Affiliated Hospital of Changchun University of Chinese Medicine | Diabetic Peripheral Neuropathy Type 2 | 02/22 | 09/22 | | |
NCT04461431: Clinical Study of Posterolateral Structure of Knee Joint Under Arthroscopy |
|
|
| Recruiting | N/A | 20 | RoW | Arthroscopic anatomical reconstruction of the posterolateral structure of the knee | Peking University Third Hospital | the Posterolateral Structure of the Knee Joint, Arthroscopy, Anatomical Reconstruction | 07/20 | 01/22 | | |
NCT05214651: A Clinical Research on Repair of Massive-large Rotator Cuff Tears |
|
|
| Recruiting | N/A | 52 | RoW | novel double row, suture bridge double row | Peking University Third Hospital | Rotator Cuff Tears | 05/26 | 05/26 | | |
NCT05383521: Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis |
|
|
| Not yet recruiting | N/A | 20 | RoW | Tinidazole 56, Tinidazole M56, Tinidazole 42, Tinidazole M42 | Shangrong Fan | Trichomonas Vaginitis | 12/25 | 12/25 | | |
NCT04456881: Arthroscopic Clinical Study of Double Bundle Anatomical Reconstruction of Medial Patellofemoral Ligament |
|
|
| Recruiting | N/A | 30 | RoW | Patients with patellar dislocation undergo patellar femoral medial reconstruction | Peking University Third Hospital | Recurrent Patellar Dislocation | 02/24 | 05/24 | | |
NCT05968001: Obinutuzumab in Chinese Real-world Patients With iNHL |
|
|
| Not yet recruiting | N/A | 400 | RoW | Obinutuzumab | Affiliated Hospital of Nantong University | Lymphomas Non-Hodgkin's B-Cell | 12/24 | 07/26 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
| Recruiting | N/A | 10000 | RoW | No intervention | Peking University People's Hospital | Dermatitis, Atopic | 10/24 | 10/24 | | |
| Wang, Wei |
| Active, not recruiting | 4 | 1127 | RoW | Yangzheng Compound Mixture, Z10970042（NMPA Approval Number）, Conventional Treatment | ShuGuang Hospital, LinkDoc Technology (Beijing) Co. Ltd., Shaanxi Buchang Pharmaceutical Co., Ltd | Carcinoma, Sleep Disorder | 09/23 | 06/24 | | |
NCT05177926: Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF) |
|
|
| Recruiting | 4 | 330 | RoW | antiviral prophylaxis with Tenofovir Alafenamide Fumarate | Nanfang Hospital of Southern Medical University, Gilead Sciences, Tigermed Consulting Co., Ltd | Hepatitis B, Chronic, Mother to Child Transmission | 12/23 | 12/23 | | |
NCT05604859: Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS) |
|
|
| Recruiting | 4 | 350 | RoW | Methylprednisolone, intravenous immunoglobulin, Tocilizumab, Low molecular weight heparin, conventional treatment | Qin Ning | Severe Fever With Thrombocytopenia Syndrome | 12/23 | 06/24 | | |
TE-ITP, NCT05583838: A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts |
|
|
| Active, not recruiting | 4 | 157 | RoW | rhTPO, Recombinant human thrombopoietin, TPIAO, Eltrombopag, Eltrombopag olamine | Institute of Hematology & Blood Diseases Hospital, China, The Second Hospital of Hebei Medical University, Xijing Hospital, The Affiliated Hospital of Inner Mongolia Medical University, The Second Affiliated Hospital of Kunming Medical University, Second Affiliated Hospital of Guangzhou Medical University, Shaanxi Provincial People's Hospital, Henan Cancer Hospital, North China University of Science and Technology Affiliated Hospital, The Second Affiliated Hospital of Dalian Medical University, Second Hospital of Shanxi Medical University, The Second Affiliated Hospital of Harbin Medical University, Shenyang Sunshine Pharmaceutical Co., LTD., First Affiliated Hospital of Xinjiang Medical University, People's Hospital of Xinjiang Uygur Autonomous Region, Kashgar 1st People's Hospital, Xi'an Central Hospital, Beijing Public Health Foundation, Yuyao People's Hospital of Zhejiang Province | Previously Treated Primary Immune Thrombocytopenia | 02/24 | 07/24 | | |
NCT06009042: Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study |
|
|
| Recruiting | 4 | 100 | RoW | IVIG 20g/d, IVIG 10g/d | Tongji Hospital | HFRS (Hemorrhagic Fever With Renal Syndrome) | 06/24 | 06/24 | | |
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis |
|
|
| Recruiting | 4 | 364 | RoW | Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult, Pseudomonas Aeruginosa Infection | 05/25 | 12/25 | | |
| Recruiting | 3 | 80 | RoW | Caffeic acid | The First Affiliated Hospital of Henan University of Science and Technology | Esophagus Cancer, Stage III | 05/21 | 05/22 | | |
| Recruiting | 3 | 400 | RoW | Tonifying Spleen and Kidney Sequential Regimen, TSKSR, Placebo of 'Tonifying Spleen and Kidney Sequential Regimen, Placebo of TSKSR | Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine, Peking University Third Hospital, Beijing Chao Yang Hospital, Jiangsu Province Hospital of Traditional Chinese Medicine, Shanghai Zhongshan Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Tianjin Union Medical Center, Henan Provincial People's Hospital, Zhengzhou Hospital of Traditional Chinese Medicine, Peking University Cancer Hospital & Institute, Chongqing University Cancer Hospital, Civil Aviation General Hospital | Colon Cancer | 05/21 | 05/21 | | |
NCT05236621: A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma |
|
|
| Active, not recruiting | 3 | 85 | RoW | Pomalidomide, Dexamethasone | Qilu Pharmaceutical Co., Ltd. | Multiple Myeloma, Recurrent or Refractory | 06/22 | 12/23 | | |
CRTCOESC, NCT02025036: Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer |
|
|
| Active, not recruiting | 3 | 249 | RoW | Capecitabine(Aibin), Aibin, Oxaliplatin(Aiheng), Aiheng, Radiotherapy, Radiation Therapy | The First Affiliated Hospital of Henan University of Science and Technology, Luoyang Central Hospital, Military 150 Hospital, Anyang Cancer Hospital, Nanyang Central Hospital, Henan Oncology Hospital, The First Affiliated Hospital of Xinyang Medical College, Sanmenxia Central Hospital | Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma | 09/22 | 04/25 | | |
NCT05188989: Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction. |
|
|
| Completed | 3 | 765 | RoW | TPN171H 2.5mg group, Simmerafil, TPN171H 5mg group, TPN171H 10mg group, Placebo group | Vigonvita Life Sciences | Erectile Dysfunction | 02/23 | 02/23 | | |
| Terminated | 3 | 372 | Europe, US, RoW | Pamrevlumab, FG-3019, Placebo | FibroGen | Idiopathic Pulmonary Fibrosis | 09/23 | 09/23 | | |
|
NCT04385550: A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma |
|
|
| Not yet recruiting | 3 | 528 | RoW | Anlotinib hydrochloride capsule, AK105 injection, Paclitaxel injection, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma | 10/23 | 12/23 | | |
NCT01815853: Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer |
|
|
| Recruiting | 3 | 620 | RoW | Neoadjuvant Chemoradiotherapy, Neoadjuvant Chemotherapy, R0 D2 Gastrectomy, Adjuvant Chemotherapy | Sun Yat-sen University, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Anhui Medical University, Liaoning Cancer Hospital & Institute, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangxi Medical University Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Zhejiang Cancer Hospital, First Hospital of China Medical University, First People's Hospital of Hangzhou | Gastric Cancer | 12/23 | 12/25 | | |
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure |
|
|
| Recruiting | 3 | 522 | RoW | D-1553 Tablet, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 10/26 | 12/27 | | |
NCT04370925: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis |
|
|
| Recruiting | 3 | 688 | RoW | Radical colectomy, HIPEC, Systemic chemotherapy | Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University | Colorectal Cancer | 04/24 | 04/26 | | |
| Recruiting | 3 | 918 | Europe, Canada, Japan, RoW | Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil | Jazz Pharmaceuticals, BeiGene, Ltd. | Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma | 12/24 | 07/25 | | |
BENCH, NCT04939142: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) |
|
|
| Active, not recruiting | 3 | 150 | RoW | SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone) | Antengene Corporation | Relapsed or Refractory Multiple Myeloma | 07/24 | 10/24 | | |
NCT04937387: Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma |
|
|
| Recruiting | 3 | 356 | RoW | FF/VI, FF/UMEC/VI, ELLIPTA | GlaxoSmithKline | Asthma | 09/24 | 09/24 | | |
NCT06004856: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia |
|
|
| Recruiting | 3 | 195 | RoW | Orelabrutinib, Placebo | Beijing InnoCare Pharma Tech Co., Ltd. | Chronic Primary Immune Thrombocytopenia (ITP) | 12/25 | 04/26 | | |
NCT05768503: Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC |
|
|
| Recruiting | 3 | 176 | RoW | Experimental drug, CAP, Control Rx, FOLFIRI+BEV | Sun Yat-sen University | Metastatic Microsatellite-stable Colorectal Cancer | 01/26 | 01/27 | | |
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer |
|
|
| Recruiting | 3 | 680 | RoW | JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy | Shanghai Junshi Bioscience Co., Ltd. | Gastric or Esophagogastric Junction Adenocarcinoma | 03/26 | 07/28 | | |
NCT05709093: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS) |
|
|
| Recruiting | 3 | 552 | RoW | Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA) | TJ Biopharma Co., Ltd. | Myelodysplastic Syndromes(MDS) | 03/27 | 03/27 | | |
| Recruiting | 2 | 189 | RoW | Fuzheng Yiliu Formulation | Guangdong Provincial Hospital of Traditional Chinese Medicine | Colorectal Cancer Stage II and III | 12/21 | 12/24 | | |
ANSWER, NCT05214222: Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 100 | RoW | Anlotinib/Penpulimab/Chemotherapy, Anlotinib, Penpulimab, Paclitaxel or Albumin Paclitaxel,Cisplatin, Penpulimab/Chemotherapy, Penpulimab, Paclitaxel or Albumin Paclitaxel,Cisplatin | Nanfang Hospital of Southern Medical University | Essential Tremor | 03/23 | 07/24 | | |
NCT06176729: Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients |
|
|
| Recruiting | 2 | 30 | RoW | Polatuzumab Vedotin, Rituximab, Lenalidomide | Yan Zhang, MD, Peking University Third Hospital, Peking University First Hospital, Chinese PLA General Hospital | Diffuse Large B Cell Lymphoma | 10/25 | 10/27 | | |
NICE, NCT04744649: Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial |
|
|
| Recruiting | 2 | 110 | RoW | XELOX or SOX, Control group, JS001+XELOX or SOX, Experimental group and Exploratory group | Nanfang Hospital of Southern Medical University, Shanghai Junshi Bioscience Co., Ltd. | Gastric Cancer, Stomach Neoplasm | 12/23 | 12/24 | | |
NCT06173037: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer |
|
|
| Not yet recruiting | 2 | 88 | RoW | RC88, RC88 for Injection | RemeGen Co., Ltd. | Primary Peritoneal Cancer, Fallopian Tube, Epithelial Ovarian | 06/26 | 12/26 | | |
NCT05292196: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation |
|
|
| Recruiting | 2 | 460 | RoW | TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Obstructive Pulmonary Disease (COPD) | 01/24 | 05/24 | | |
NAUTICALCRC, NCT05004350: A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer. |
|
|
| Active, not recruiting | 2 | 103 | RoW | Encorafenib, Braftovi®, PF-07263896, W0090, LGX818, ONO-7702, Cetuximab, Erbitux®, C225, FOLFIRI, Folinic acid + Fluorouracil + Irinotecan | Pierre Fabre Medicament, Merck KGaA, Darmstadt, Germany | BRAF V600E, Metastatic Colorectal Cancer | 12/23 | 01/25 | | |
NCT03941574: A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy |
|
|
| Recruiting | 2 | 108 | RoW | HLX10 | Shanghai Henlius Biotech | MSI-H Solid Malignant Tumor | 05/24 | 06/26 | | |
NCT04297995: Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors |
|
|
| Active, not recruiting | 2 | 131 | RoW | HLX10, HLX07, HLX07 placebo, Cisplatin/Carboplatin, 5-FU | Shanghai Henlius Biotech | Head and Neck Squamous Cell Carcinoma | 05/24 | 06/25 | | |
NCT06454968: Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma. |
|
|
| Recruiting | 2 | 45 | RoW | Orelabrutinib, obinutuzumab, lenalidomide | Peking Union Medical College Hospital | Marginal Zone Lymphoma | 06/26 | 06/28 | | |
NCT05810350: Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles |
|
|
| Recruiting | 2 | 40 | RoW | Aumonertinib 165mg orally once daily and intrathecal chemotherapy with pemetrexed | Three Gorges Hospital of Chongqing University | Non-small Cell Lung Cancer | 12/24 | 12/24 | | |
CEIL, NCT05959356: Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer |
|
|
| Recruiting | 2 | 198 | RoW | Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab or c225, Envafolimab, Irinotecan, Oxaliplatin, Leucovorin, 5-FU, Cetuximab + mFOLFOX6/FOLFIRI | Sun Yat-sen University | Metastatic Colorectal Cancer | 12/25 | 12/27 | | |
HATCH, NCT04691141: A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS) |
|
|
| Terminated | 1/2 | 15 | RoW | ATG-016 | Shanghai Antengene Corporation Limited | Myelodysplastic Syndrome | 09/23 | 09/23 | | |
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies |
|
|
| Recruiting | 1/2 | 1300 | Canada, US, RoW | SKB264 | Klus Pharma Inc. | Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer | 08/25 | 07/26 | | |
NCT06106841: TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL) |
|
|
| Recruiting | 1/2 | 39 | RoW | 400mg of TQB3909 tablets, 600mg of TQB3909 tablets | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Mantle Cell Lymphoma | 12/24 | 12/24 | | |
NCT04324138: Efficacy and Safety of Jianpi Qinghua Granules in Patients With Nonerosive Reflux Disease |
|
|
| Recruiting | 1 | 78 | RoW | Jianpi Qinghua granules, experimental drugs, Jianpi Qinghua placebo granules, placebo | Xiyuan Hospital of China Academy of Chinese Medical Sciences, Liaoning University of Traditional Chinese Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine | Nonerosive Reflux Disease | 12/21 | 12/21 | | |
NCT02915445: EpCAM CAR-T for Treatment of Advanced Solid Tumors |
|
|
| Active, not recruiting | 1 | 30 | RoW | EpCAM CAR-T cells | Sichuan University | Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M), Breast Cancer Recurrent, Gastric Cancer With Metastasis | 07/25 | 07/25 | | |
CARTinNS, NCT04561557: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System |
|
|
| Recruiting | 1 | 36 | RoW | CT103A cells, Cyclophosphamide and fludarabine | Tongji Hospital, Nanjing IASO Biotechnology Co., Ltd. | Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Idiopathic Inflammatory Myopathies, Multiple Sclerosis, Autoimmune Encephalitis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), POEMS Syndrome | 02/27 | 05/27 | | |
NCT04893759: A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors |
|
|
| Recruiting | 1 | 60 | RoW | Pelcitoclax, APG-1252 | Ascentage Pharma Group Inc. | Neuroendocrine Tumors | 06/24 | 06/25 | | |
NCT05473624: Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 153 | RoW | HRS-1167 | Jiangsu HengRui Medicine Co., Ltd. | Advanced Solid Tumors | 12/24 | 12/24 | | |
| Recruiting | N/A | 196 | RoW | CRT, concurrent chemoradiotherapy, surgery, esophagectomy | The First Affiliated Hospital of Henan University of Science and Technology, Jiangsu HengRui Medicine Co., Ltd., Anyang Tumor Hospital, 150th Hospital of PLA | Esophagus Cancer | 12/20 | 06/21 | | |
NCT04861376: Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia |
|
|
| Not yet recruiting | N/A | 174 | RoW | Pueraria lobata, Pueraria thomsoni, Placebo | Jiangxi University of Traditional Chinese Medicine | Dyslipidemias | 08/21 | 12/21 | | |
NCT04886193: FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis |
|
|
| Recruiting | N/A | 20 | RoW | FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1) | Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanghai Junshi Bioscience Co., Ltd. | Chemotherapy, Gastric Cancer | 05/22 | 05/23 | | |
NCT04360577: Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant Chemotherapy |
|
|
| Completed | N/A | 240 | RoW | acupuncture | Guangzhou University of Traditional Chinese Medicine, First Affiliated Hospital, Sun Yat-Sen University, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Sixth Affiliated Hospital, Sun Yat-sen University, Southern Medical University, China, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Guangzhou Medical University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Fifth Affiliated Hospital, Sun Yat-Sen University, First People's Hospital of Foshan, Yuebei People's Hospital | Stomach Neoplasms | 03/23 | 05/23 | | |
| Recruiting | N/A | 100 | RoW | Automated peritoneal dialysis, Intermittent hemodialysis | Limeng Chen, First Hospital of China Medical University, First Affiliated Hospital Xi'an Jiaotong University, Beijing Anzhen Hospital, Xiangya Hospital of Central South University, Baxter Healthcare Corporation | Acute Kidney Injury | 12/22 | 12/22 | | |
NCT03792932: Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer |
|
|
| Recruiting | N/A | 306 | RoW | Laparoscopic distal pancreatectomy, Open distal pancreatectomy | Fudan University | Pancreatic Cancer, Surgery, Laparoscopy | 01/23 | 01/23 | | |
GIANT, NCT04765592: Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System ( Study) |
|
|
| Active, not recruiting | N/A | 88 | RoW | WeFlow-Arch Modeler Embedded Branch Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Aortic Arch Aneurysm | 02/25 | 02/29 | | |
NCT04853238: Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China |
|
|
| Completed | N/A | 1507 | RoW | Prospective observational cohort study | GlaxoSmithKline | Pulmonary Disease, Chronic Obstructive | 11/22 | 02/23 | | |
SELECT-1, NCT04397432: Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Retrospective Study |
|
|
| Active, not recruiting | N/A | 878 | RoW | | Tian Xie, LinkDoc Technology (Beijing) Co. Ltd. | Carcinoma, Non-Small-Cell Lung | 04/23 | 03/26 | | |
DELTA, NCT05608655: DKutting Balloon Versus Chocolate Balloon to Treat Femoral and Popliteal Artery Stenosis |
|
|
| Completed | N/A | 188 | RoW | DKutting LL balloon, Chocolate balloon | DK Medical Technology (Suzhou) Co., Ltd. | Femoral Artery Stenosis, Popliteal Artery Stenosis | 01/24 | 02/24 | | |
NCT04688944: The Correlation Between Degeneration of Paraspinal Muscle and Outcome of Patients With Lumbar Spinal Stenosis |
|
|
| Recruiting | N/A | 200 | RoW | observation | Peking University Third Hospital | Lumbar Spinal Stenosis, Paraspinal Muscle | 10/23 | 01/24 | | |
NCT05193162: Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases |
|
|
| Recruiting | N/A | 800 | RoW | No any intervention, have no any intervention | Ruijin Hospital | Pancreatic Cancer, Pancreatic Disease, Microbial Colonization | 12/23 | 07/26 | | |
NCT06011902: A 6-month Follow-up Study of Patients With Severe Fever With Thrombocytopenia Syndrome |
|
|
| Recruiting | N/A | 1500 | RoW | | Tongji Hospital | Severe Fever With Thrombocytopenia Syndrome | 12/23 | 03/24 | | |
| Recruiting | N/A | 500 | RoW | | Tongji Hospital | HFRS | 12/23 | 12/23 | | |
NCT04423354: A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEG |
|
|
| Recruiting | N/A | 94 | RoW | Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Type Ⅱ Adenocarcinoma of Esophagogastric Junction | Guangdong Provincial Hospital of Traditional Chinese Medicine | Esophagogastric Junction Adenocarcinoma, Siewert Type II Adenocarcinoma of Esophagogastric Junction | 02/24 | 03/24 | | |
| Not yet recruiting | N/A | 600 | NA | Primary angle closure diseases | Zhongshan Ophthalmic Center, Sun Yat-sen University | Primary Angle-Closure Glaucoma | 09/24 | 09/24 | | |
NCT06467773: TSPO-PET/MRI in Surveillance of Neuroinflammation in the Central Nervous System |
|
|
| Not yet recruiting | N/A | 100 | RoW | Radiation: PET-MRI with [18F]-DPA-714 | Tongji Hospital, Wuhan Jianmin DAPENG Pharmaceutical Co., Ltd. | Central Nervous System Diseases | 06/29 | 12/29 | | |
NCT05992701: Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease |
|
|
| Recruiting | N/A | 28 | RoW | Directional deep brain stimualtion | Beijing Pins Medical Co., Ltd, Beijing Tiantan Hospital, Changhai Hospital, the Second Military Medical University, Shenzhen Second People's Hospital, Wuhan University, West China Hospital, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, First Affiliated Hospital of Kunming Medical University, Nanjing Medical University, Tianjin Medical University General Hospital | Parkinson's Disease | 06/24 | 06/24 | | |
NCT06385379: Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study) |
|
|
| Recruiting | N/A | 90 | RoW | WeFlow-Tribranch embedded aortic Triple-branch arch Stent Graft system | Hangzhou Endonom Medtech Co., Ltd. | Aortic Arch Aneurysm | 12/25 | 12/30 | | |
NCT06474507: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD) |
|
|
| Not yet recruiting | N/A | 230 | RoW | Calculus bovis sativus (CBS) | Tongji Hospital, Wuhan Jianmin DAPENG Pharmaceutical Co., Ltd. | Ischemic Cerebrovascular Disease, Acute Ischemic Stroke, Cerebral Small Vessel Diseases | 07/29 | 12/29 | | |
NCT06474520: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD) |
|
|
| Not yet recruiting | N/A | 250 | RoW | Calculus bovis sativus (CBS) | Tongji Hospital, Wuhan Jianmin DAPENG Pharmaceutical Co., Ltd. | Idiopathic Inflammatory Demyelinating Disease, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Acute Disseminated Encephalomyelitis | 07/29 | 12/29 | | |
| Recruiting | N/A | 330 | RoW | | Ruijin Hospital | Pancreatic Cancer, Pancreatic Disease | 07/24 | 12/25 | | |
NCT04967560: The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD |
|
|
| Recruiting | N/A | 64 | RoW | deep brain stimulation | Shanghai Mental Health Center, West China Hospital, Huashan Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Brain Hospital, First Affiliated Hospital of Kunming Medical University, Changhai Hospital, SceneRay Corporation, Limited | Obsessive-Compulsive Disorder | 07/24 | 10/24 | | |
NCT03651986: Diagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary Nodules |
|
|
| Active, not recruiting | N/A | 10560 | RoW | ctDNA methylation analysis by NGS | AnchorDx Medical Co., Ltd., Xiangya Hospital of Central South University, West China Hospital, Shanghai Zhongshan Hospital, Shanghai Pulmonary Hospital affiliated to Tongji University, First Hospital of China Medical University, Guizhou Provincial People's Hospital, Shanghai Chest Hospital, First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital Xi'an Jiaotong University, Qilu Hospital of Shandong University, Inner Mongolia People's Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of Zhengzhou University, Second Hospital of Jilin University, LanZhou University, Peking University Third Hospital, The First People's Hospital of Yunnan, Shantou Affiliated Hospital of Sun Yat-Sen University, Ruijin Hospital, The Shanghai Jiao Tong University Medical School, Tongji Hospital, The First Affiliated Hospital of Guangzhou Medical University, Xijing Hospital, Air Force Medical University of PLA, Shenzhen People's Hospital, Henan Provincial People's Hospital, Beijing Chao Yang Hospital, Xiamen Second Hospital, The First Affiliated Hospital of Nanchang University | Pulmonary Nodules | 09/24 | 06/25 | | |
NCT05638269: A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China |
|
|
| Recruiting | N/A | 12000 | RoW | no intervention | Zhujiang Hospital, National Natural Science Foundation of China | Essential Hypertension, Liver Cancer, Nasopharyngeal Cancer, Pancreatic Cancer, Lung Cancer, Chronic Kidney Diseases, Acute Coronary Syndrome, Epilepsy, Gastric Cancer, Primary Aldosteronism, Subclinical hypothyroïdism | 12/24 | 12/25 | | |
NCT05346705: Effects of Newly-created Individualized Upper Airway Muscle Functional Training on Patients With OSA |
|
|
| Recruiting | N/A | 300 | RoW | New individualized upper airway muscle functional training | First Hospital of China Medical University | Obstructive Sleep Apnea, Muscle Disorder | 01/25 | 05/25 | | |
NCT06036563: Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing |
|
|
| Recruiting | N/A | 3200 | RoW | | Air Force Military Medical University, China, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Tang-Du Hospital, The First Affiliated Hospital of Guangzhou Medical University, First Hospital of China Medical University, People's Hospital of Ningxia Hui Autonomous Region, Xinjiang Medical University, Guanxian People's Hospital | Cancer Diagnosis, LungCancer, Gastric Cancer, Liver Cancer, Colorectal Cancer, Esophagus Cancer, Breast Cancer, Pancreas Cancer | 08/25 | 12/25 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
NCT04440605: A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis |
|
|
| Recruiting | N/A | 968 | RoW | Preoperative staging——D2 gastrectomy——Postoperative staging | Peking University, RenJi Hospital, Ruijin Hospital, West China Hospital, Beijing 302 Hospital, Fudan University, Peking University International Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Fujian Medical University Union Hospital, First Affiliated Hospital Xi'an Jiaotong University, Chinese PLA General Hospital, First Affiliated Hospital of Xinjiang Medical University, Tianjin Medical University General Hospital, The Second Affiliated Hospital of Dalian Medical University, Wuhan Union Hospital, China, Peking University People's Hospital, Weifang People's Hospital, Second Hospital of Jilin University, Fujian Province Tumor Hospital, Shanxi Province Cancer Hospital, The First Affiliated Hospital of Nanchang University, Tianjin Medical University Cancer Institute and Hospital, Shanghai Zhongshan Hospital, First Affiliated Hospital, Sun Yat-Sen University, The Affiliated Hospital of Qingdao University, The First Affiliated Hospital of Xiamen University, Beijing Hospital, Beijing Friendship Hospital, Qingdao Municipal Hospital, Guangdong Provincial People's Hospital, Affiliated Hospital of Qinghai University, Shandong Provincial Hospital, First Hospital of Jilin University, Nanfang Hospital of Southern Medical University, Zhongshan Hospital Xiamen University, Hebei Medical University Fourth Hospital | Gastric Cancer, Gastric Cancer Stage, CT, Neoadjuvant Therapy | 04/22 | 10/22 | | |
| Recruiting | N/A | 400 | RoW | | China-Japan Friendship Hospital, Chinese Academy of Medical Sciences, Second Affiliated Hospital, School of Medicine, Zhejiang University, Capital Medical University, Peking University Third Hospital, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Obstructive Pulmonary Disease | 01/25 | 12/25 | | |
| Recruiting | N/A | 50000 | RoW | comprehensive management algorithm for preventing mother-to-child transmission of HBV | Nanfang Hospital of Southern Medical University, Chinese Foundation for Hepatitis Prevention and Control, Tigermed Consulting Co., Ltd | Hepatitis B, Chronic, Mother to Child Transmission | 06/25 | 12/25 | | |
| Zhang, Bo |
NCT06263348: A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes |
|
|
| Recruiting | 4 | 2000 | RoW | Dorzagliatin tablets | Hua Medicine Limited, Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd. | Type2diabetes | 04/26 | 04/26 | | |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED ) |
|
|
| Recruiting | 4 | 9000 | RoW | Aspirin 100 mg Oral Tablet, Matching Placebo | Guangdong Provincial People's Hospital, The George Institute | CKD (Chronic Kidney Disease) Stage 5D | 09/26 | 12/26 | | |
| Not yet recruiting | 3 | 8862 | RoW | Colchicine 0.5 mg, no other name, Colchicine 0.375 mg, Placebo | Wuhan Union Hospital, China | Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine | 03/28 | 08/28 | | |
RIDER, NCT05794971: Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases |
|
|
| Recruiting | 3 | 126 | RoW | Regorafenib and DIBIRI, Drug: Irinotecan, Procedure: TACE, Device: drug eluting-bead, Regorafenib | Sun Yat-sen University | Colorectal Cancer Liver Metastases, Regorafenib | 03/27 | 03/28 | | |
| Recruiting | 1/2 | 300 | RoW | OH2 injection, with or without irinotecan or HX008 | Binhui Biopharmaceutical Co., Ltd. | Solid Tumor, Gastrointestinal Cancer | 08/24 | 08/24 | | |
NCT04936178: A Study of NB003 in Patients With Advanced Malignancies |
|
|
| Recruiting | 1 | 258 | Europe, US, RoW | NB003 tablets | Ningbo Newbay Technology Development Co., Ltd | Advanced Solid Tumor | 07/25 | 12/25 | | |
NCT04121520: Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey |
|
|
| Completed | N/A | 200 | Europe, Japan, RoW | Questionnaire | Hepatopancreatobiliary Surgery Institute of Gansu Province, LanZhou University, Shandong Provincial Hospital, Xingtai People's Hospital, Zhejiang University, Ankara University, Chiba University Graduate School of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, S. Orsola-Malpighi Hospital, University of Bologna, Universidade Federal de Pernambuco, Hanyang University College of Medicine | Portal Hypertension, Cirrhosis, Liver | 08/21 | 08/22 | | |
COOPERATION, NCT04912518: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction |
|
|
| Recruiting | N/A | 250 | RoW | Dexmedetomidine (DEX), Placebo (Saline) | Harbin Medical University, Yangtze River Pharmaceutical Group Co., Ltd. | ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection | 12/22 | 12/22 | | |
NCT05375123: Reference Range for Tissue Motion Tracking of Mitral Annulus Displacement in Chinese Han Singleton Pregnancies |
|
|
| Recruiting | N/A | 660 | RoW | Ultrasound image acquisition | First Hospital of China Medical University | Pregnancy | 06/23 | 06/24 | | |
NCT05547841: Normal Reference Value for Echocardiography in Chinese Han Pregnancies |
|
|
| Recruiting | N/A | 680 | RoW | Echocardiography acquisition | First Hospital of China Medical University | Pregnancy | 08/23 | 08/24 | | |
